Long-Term Efficacy and Safety of Pegvisomant in Combination With Long-Acting Somatostatin Analogs in Acromegaly - Concepedia

Concepedia

Publication | Closed Access

Long-Term Efficacy and Safety of Pegvisomant in Combination With Long-Acting Somatostatin Analogs in Acromegaly

122

Citations

28

References

2014

Year

Sebastian Neggers, Sanne Franck, Felix W.M. de Rooij, A.H.G. Dallenga, R. M. L. Poublon, Richard A. Feelders, J. A. M. J. L. Janssen, Michael Buchfelder, Leo J. Hofland, Jens Otto Lunde Jørgensen,

The Journal of Clinical Endocrinology & Metabolism

Abstract

The combination treatment with LA-SRIFs and PEGV was effective in 97% of the patients, it appears to be a safe medical treatment and it reduces the required dose of PEGV.

References

	Year	Citations

Page 1